NewGenIvf Group annual shares outstanding
2022
2023
2024
2025
NewGenIvf Group Shares Outstanding History (NIVF)
NewGenIvf Group reported 240,622 shares outstanding at the end of fiscal 2025.
View full NewGenIvf Group company overviewNewGenIvf Group annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 240,622 | 240,242 | +63221.58% |
| 2024 | 2024-12-31 | 380 | −507,089 | −99.93% |
| 2023 | 2023-12-31 | 507,469 | −94,361 | −15.68% |
| 2022 | 2022-12-31 | 601,830 | — | — |
NewGenIvf Group quarterly shares outstanding
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 240,622 | — | — |
| Q4 2024 | 2024-12-31 | 380 | — | — |
| Q4 2023 | 2023-12-31 | 507,469 | — | — |
| Q4 2022 | 2022-12-31 | 601,830 | — | — |
NewGenIvf Group shares outstanding trends
Across the available reported history, NewGenIvf Group's shares outstanding moved from 380 to 240,622, a change of 240,242. The latest reported quarter, Q4 2025, shows 240,622.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewGenIvf Group filings at SEC.gov ↗